ReviewRSC advances2022
Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics.
Md Abdus SubhanPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ReviewRSC advances2022
Md Abdus SubhanPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.